Catalyst Wire Dossier Catalyst Wire Dossier

Tralokinumab

tralokinumab
Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for Tralokinumab, covering 2016-04-05 to 2026-08-05. Get the full timeline:

Most recent: Clinical Trial Results: A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy [Phase 3]

See pricing